Status:
UNKNOWN
Design Of WELL Being Monitoring Systems, Application in Autism
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Autistic Disorder
Eligibility:
All Genders
12-25 years
Phase:
NA
Brief Summary
The worldwide prevalence of autism is constantly increasing. People with autisms have difficulties in communication and social interaction resulting from atypical perceptual and information processing...
Detailed Description
The protocol will take place in real life (home and social environments). We aim to associate modifications of ANS with external events which will all be recorded in a synchrony manner through a speci...
Eligibility Criteria
Inclusion
- Clear autism spectrum disorder, based on the autism diagnostic interview - revised (ADI-R), the autism diagnostic observation schedule - generic (ADOS-G), and the Vineland adaptive behavior scales (VABS).
Exclusion
- change in medical prescription in the previous 3 months and during the experiment.
- The same inclusion criteria will apply for the paired age and sex matched individuals with the exception of autism spectrum. The paired control will be chosen within the friends of individuals with autism. In case of difficulty to recruit controls, the psychologist referent may be served as control.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02275455
Start Date
October 1 2014
End Date
December 1 2018
Last Update
July 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Clermont-Ferrand (CHU), France
Clermont-Ferrand, France, France, 63000